Quantel Medical, which develops and markets diagnostic ocular ultrasound systems and surgical lasers, has expanded its U.S. operation.
Bozeman, MT-Quantel Medical, which develops and markets diagnostic ocular ultrasound systems and surgical lasers, has expanded its U.S. operation.
The company, founded in 1993 in Clermont-Ferrand, France, said it hopes to use its U.S. organization in Bozeman, MT, to increase brand recognition within the U.S. eye-care industry and to facilitate product integration and innovation in the U.S. market as a whole.
“Quantel’s ophthalmology business has been growing in excess of 20% per year for each of the past 3 years, driven by new product introductions and good customer service,” said Peter Falzon, general manager of the Quantel USA Inc. medical division. “Our strategy to invest more in the U.S. market will result in more sales, marketing, training, and technical resources in the field to support our customers.”
Recent additions to the product line include an ultrasound platform offering seven probes, including a 50-MHz ultrasound biomicroscopy probe, and a photocoagulator platform that offers pattern-scanning and micropulse technology.
“Quantel is uniquely positioned in today’s ophthalmology market for three reasons: Our well-recognized and reputable name in ophthalmology, our presence in 85 countries around the world, and our capacity to develop and commercialize innovative products quickly,” said Jean-Marc Gendre, chief executive officer. “We are looking forward to establishing a wider customer base in the United States.”
For more articles in this issue of Ophthalmology Times eReport, click here.